Abstract
Aims
To explore how people who use fentanyl and health-care providers engaged in and responded to overdose risk communication interactions, and how these engagements and responses might vary by age.
Design
A single-site qualitative in-depth interview study.
Setting
Boston, MA, United States.
Participants
The sample included 21 people (10 women, 11 men) who were either 18–25 or 35+, English-speaking, and reported illicit fentanyl use in the last year and 10 health-care providers who worked directly with people who use fentanyl (PWUF) in clinical and community settings.
Measurements
Open-ended, flexible interview questions guided by a risk communication framework were used in all interviews. Codes used for thematic analysis included deductive codes related to the risk communication framework and inductive, emergent codes from interview content.
Findings
We identified potential age-based differences in perceptions of fentanyl overdose, including that younger participants appeared to display more perceptions of an immunity to fentanyl’s lethality, while older people seemed to express a stronger aversion to fentanyl due to its heightened risk of fatal overdose, shorter effects and potential for long-term health consequences. Providers perceived greater challenges relaying risk information to young PWUF and believed them to be less open to risk communication. Compassionate harm reduction communication was preferred by all participants and perceived to be delivered most effectively by community health workers and peers. PWUF and providers identified structural barriers that limited compassionate harm reduction, including misalignment of available treatment with preferred options and clinical structures that impeded the delivery of risk communication messages.
Conclusions
Among people who engage in illicit fentanyl use, fentanyl-related risk communication experiences and preferences may vary by age, but some foundational elements including compassionate, trust-building approaches seem to be preferred across the age spectrum. Structural barriers in the clinical setting such as provider-prescribing power and infrequent encounters may impede the providers’ ability to provide compassionate harm reduction communication.
Keywords: Age-based preferences, drug overdose, fentanyl, harm reduction, risk communication, qualitative
INTRODUCTION
Deaths from illicitly manufactured fentanyl and its analogues (herein referred to as ‘fentanyl’) in the United States have increased 13-fold over the last decade [1]. In 2018, fentanyl was responsible for 67% of opioid-related deaths nationally, but 93% of opioid-related deaths in Massachusetts [2,3]. Fentanyl as the major driver of opioid overdose deaths is likely related to changes in supply, policies that limit opioid prescribing, and contamination of the stimulant and sedative drug supply [4-8]. Since the introduction of fentanyl, people who use drugs are at significantly higher risk of overdose and may have minimal agency to avoid fentanyl use [9-12].
Fentanyl has increased the urgency for expanded access to harm reduction services. Strategies including fentanyl testing strips, using appearance-based drug assessments (e.g. color), overdose prevention counseling, and creating safer spaces for people to use drugs have been reported [10,11,13-17]. Current US strategies to curb overdose emphasize concrete services, like increased naloxone distribution [18] and expanded uptake of medications for opioid use disorder, but focus less on how to change risk behaviors. There remains a gap in the literature on how to most effectively implement harm reduction services to optimize uptake [14,18-20]. The limiting factor may not be only lack of services, but also effective communication that motivates reductions in overdose risk behaviors and increases in harm reduction service use.
Broad-based harm reduction communications have focused on education about the dangers of fentanyl and relied heavily on public health ‘drug alerts’ – flyers from authorities notifying people of an acute outbreak of overdoses [21-23]. Yet these approaches have not achieved widespread changes in opioid-related mortality. Where there are persistently elevated rates of overdose among high risk populations, there are opportunities to improve risk communication [24]. One-on-one risk communication is a complementary approach to community-level messages about the risks of fentanyl with the goal of reducing overdose. One-on-one overdose risk communication can be delivered by a variety of care providers (clinicians, outreach workers, counselors, peers), but is especially relevant for harm reduction providers [25]. Risk communication usually includes both non-directive (informing) messages alongside those that seek to elicit behavior change (influencing), although the balance of these two activities may differ across contexts [26]. One inherent challenge for harm reduction providers is avoiding the perception of coercing behavior change in upholding the principles of harm reduction [27]. Another challenge is that among people at high-risk for overdose prevention messages must compete with other more imminent risks and challenges faced by PWUF, including avoiding arrest and assault, finding money to buy drugs, and securing shelter [28]. Effective risk communication requires an understanding of the context in which messages are delivered and input from the intended audience at all levels of design [29,30]. PWUF’s perspectives have been limited in the design of current communication efforts to reduce overdose and there is limited research on sources of risk communication and resulting perceptions and behaviors [22,31].
Age is an important factor in how people respond to risk information [32], yet few studies directly compare risk behaviors across age groups. One study in Seattle documented that people < 30 years old who use heroin were more likely to re-use and share syringes compared to those over 30 [33]. Other studies among young adults who inject drugs further suggest that they employ few risk reduction behaviors, and knowledge of overdose risk factors does not produce behavior change [34,35]. Lack of behavior change in young adults is sometimes attributed to their developmental stage, characterized by feelings of impulsivity, and increased risk tolerance [36,37]. This is further supported by some data suggesting that younger age is associated with seeking fentanyl over less potent opioids [38]. Young adults may therefore benefit from tailored communication strategies that differ from older adults [32]. Given the paucity of data comparing preferences for risk communication and harm reduction across ages, this qualitative study aimed to characterize 1) how people who use fentanyl and providers engaged in and responded to overdose risk communication interactions, and 2) explore whether these engagements and responses varied by age.
METHODS
Study design
We conducted a single-site qualitative in-depth interview study to describe experiences with and preferences for risk communication among 21 people who use fentanyl-containing opioids (‘PWUF’) and 10 clinical and community providers (‘providers’).
Recruitment
We utilized purposive sampling to target three groups: younger PWUF (ages 18–25), older PWUF (ages 35+), and health care providers. We chose the two age groupings using a purposive maximum variation approach [39], while reflecting CDC age-based groupings [40], enhancing our ability to detect possible age differences by examining two tails on the age spectrum. Flyers and staff referrals recruited PWUF from local syringe service programs, community outreach services, and primary care practices. Most participants were referred from public health-funded community programs serving those who have unstable housing who utilize programs for basic services (syringe services, bathroom facilities, internet access) and represent a group with a high burden of mental health and substance use disorders [16]. We included individuals ages 18–25 or 35+; who were English-speaking, and reported illicit fentanyl use within the last year. We enrolled 21 PWUF, with balanced numbers of men and women in each age cohort. Providers from clinical and community-based settings who worked directly with PWUF were invited by email to participate and 10 enrolled. We defined ‘clinical providers’ as professionals working in medical settings, while ‘Community Health Workers’ (CHWs) were those who practiced outside of institutional medical environments (e.g. outreach programs). All participants were briefed on the study purpose, risks, and benefits and provided informed consent before interviews. This research was reviewed and approved by the Boston Medical Center Institutional Review Board.
Qualitative guide development
We used open-ended, flexible interview guides for all interviews. Guides were drafted by the study team, including two addiction medicine clinicians and a qualitative health services researcher. A risk communication framework (Fig. 1) designed for practitioners communicating about health risks, guided interview development and analysis. The framework describes four elements of risk communication, including: 1) Providing information about the risk (of using fentanyl); 2) Providing information to eliminate risk; 3) counseling about harm reduction; and 4) Reassuring continued care. Each of the four components of risk communication was considered in PWUF’s and providers’ interviews and was used to develop initial codes for analysis. Interview guides were tested prior to study initiation on volunteer community health workers, research staff, and practicing clinicians (n = 6).
Figure 1.
Four elements of risk communication framework
Qualitative interviews
Interviews occurred from May–November 2018. Trained research assistants conducted 40–60 minute interviews with PWUF in-person. Interviews covered: 1) Fentanyl risk communication experience, including what they have learned about fentanyl, how and from whom; 2) Preferences for risk communication, specifically what communications would most impact behavior; 3) Current and preferred harm reduction practices; and 4) Relative concern about fentanyl overdose risk in relation to other concerns. Participants received a $50 debit card at the interview’s conclusion. Provider interviews were conducted in-person or by phone and lasted 30–60 minutes. These covered: 1) Current communication practices about fentanyl and overdose risks; 2) Facilitators and barriers to communicating effectively; and 3) Strategies to improve fentanyl-related risk communication. Providers received $75 compensation. Interviews were audio-recorded and professionally transcribed verbatim. Research assistants reviewed transcripts against audio files for fidelity.
Analysis
Interview transcripts were imported into NVivo qualitative data management software version 12.1 and analyzed using a grounded content analysis [41,42], combining deductive and inductive thematic development approaches. The lead author drafted a codebook with deductive codes based on the risk communication framework and through codebook development with five transcripts, identified inductive codes related to communication factors, fentanyl, and overdose risk perception [43]. Each transcript was coded independently by two coders, examined for agreement [44,45], and discrepancies resolved by the study team. Coding queries were used to build content themes around risk communication and compare strategies that were employed versus those desired. We examined codes by age group to assess commonalities and differences in themes between younger and older participants. Coding and theme development was repeated separately for providers. After analysis within each perspective, themes were compared across the PWUF and provider groups. Names reported in the text below are pseudonyms randomly generated to protect participant confidentiality.
RESULTS
Table 1 displays the demographics of the 21 enrolled PWUF and 10 providers. Of the PWUF, 10 were ages 18–25 and 11 were 35+. More participants who were 35 + reported actively avoiding fentanyl (n = 7) versus those 18–25 (n = 1). Most participants were in treatment or receiving care at the time of the interview (n = 9, 18–25, n = 6, 35+). All PWUF and providers engaged in at least one element of the risk communication framework, although some elements were reported more often by older PWUF (Table 2). Below we present 3 themes characterizing how PWUF and providers engaged in and responded to risk communication interactions as conceptualized in the guiding framework.
Table 1.
Participant characteristics
| PWUF (N = 21) |
|||
|---|---|---|---|
| Age 18–25 (n = 10) |
Age 35+ (n = 11) |
Total | |
| Gender | |||
| Male | 5 | 6 | 11 |
| Female | 5 | 5 | 10 |
| Fentanyl-seeking* | |||
| Active | 1 | 1 | 2 |
| Passive | 6 | 3 | 9 |
| No | 3 | 7 | 10 |
| In treatment** | |||
| Yes | 9 | 6 | 15 |
| No | 1 | 4 | 5 |
| Unsure | 0 | 1 | 1 |
|
Providers (N = 10) |
|||
| Clinical (n = 4) | CHW (n = 6) | Total | |
| Gender | |||
| Male | 1 | 2 | 3 |
| Female | 3 | 4 | 7 |
CHW = Community Health Workers.
Fentanyl-seeking was categorized as either ‘active’ (a person who wants to use fentanyl), ‘passive’ (a person who uses fentanyl but does not seek it) or ‘no’ (a person who does not want to use fentanyl).
Participants were defined as being in treatment if they were on medication for opioid use disorder, were in a detox or residential treatment program or enrolled in a program providing treatment for substance use disorder. PWUF = people who use fentanyl.
Table 2.
Elements of risk communication discussed by participants, reported as n (%)
| Communication element | PWUF 18–25 | PWUF 35+ | All PWUF | Providers |
|---|---|---|---|---|
| Information about risk | 5 (50%) | 7 (64%) | 12 (57%) | 7 (70%) |
| Eliminate risk | 6 (60%) | 10 (91%) | 16 (76%) | 5 (50%) |
| Discuss harm reduction | 8 (80%) | 7 (64%) | 15 (71%) | 10 (100%) |
| Reassure continued care | 1 (10%) | 6 (55%) | 7 (33%) | 4 (40%) |
PWUF = people who use fentanyl.
Theme 1: Older PWUF were more concerned with fentanyl-related fatal overdose than younger PWUF and modified their behavior accordingly. Providers perceived greater challenges relaying risk information to young adults.
In responding to messages about the risks of fentanyl, seven older PWUF described an aversion to fentanyl, due to its inconsistent effects, shorter duration, heightened risk of fatal overdose, and potential for long-term health consequences.
‘I hate [fentanyl], a lot of us do not like it… It works for 20 minutes and then it goes away… when you are doing a huge booming shot of fentanyl and your body is not used to it and whatever, you are going down’ (Alana).
‘This is a person that was using for so many years. Look what it did to his liver. Look how much he’s lost of his brain capacity. This is what’s going to happen to you. I wish I would have had that information then.’ (Tim)
Older PWUF who were attempting to avoid fentanyl described switching substances, declining fentanyl when offered, and utilizing discretion when obtaining drugs:
‘I switched over to straight cocaine, I do not mess with heroin cause … it’s fentanyl.’ (Vincente)
‘I do not subject myself to buying drugs just from anyone. If it’s one individual that I have purchased my drug of choice from, I will go to them and only them. If they are not available, I will not go out just jumping and getting some from just anyone … it’s better off to just wait … they do not give two cramps[sic] if they end up killing you.’ (Kathy)
Younger respondents described nonfatal overdose as a primary risk related to fentanyl use, although only half said they were fearful of overdose in contrast to the majority in the 35 + group. Many, like Jared, acknowledged ‘I’m just not scared when I’m out there. I just go all in.’ When most young people described the moments using fentanyl, they did so with feelings of confidence and immunity, dismissing that overdose risk applies to them:
‘I feel like myself and other addicts always think that – ‘Oh, [overdose is] not going to happen to me … Oh, I know how much to do … I know, I’ve been doing this for years. I know how to use. I know how much is too much.” (Anabel)
While all but one younger PWUF recalled a history of at least one overdose, such experiences did not always translate into concerns about future overdose fatality:
‘I overdosed and I came out of it. It did not even phase me in the slightest way. I came very close to death and I just kind of brushed it off, went about my day as usual … And even now I do not look back on it in a traumatic way or like – it honestly did not affect me.’ (Brent)
As Brent stated here, surviving overdose did not catalyze behavior change. Young PWUF either perceived risk of withdrawal as greater than risk of overdose or felt immune to overdose risk. Seven providers similarly perceived that younger PWUF had a sense of immunity that was difficult to overcome, impeding risk communication and behavior change:
‘There’s a lot more arrogance and their sense of immunity to it that I do not find in older, more seasoned users … So, they are a little more resistant to receiving information … Because these new users have started using and come up in the age of fentanyl, they are very aware of what they are using. They’re like, ‘yeah that’s Feddy. Yeah I’ve overdosed this many times.’ (Joyce, Clinical Provider)
Some young people expressed fear, but described being unable to consistently use harm reducing behaviors despite knowing what to do. Savannah described this experience and her desire for overdose response and prevention education:
‘I’d try to have Narcan on me but I would not always… It was all in secret. It was all like me using in the bathroom and coming out like nothing happened. And that’s also why it was so dangerous, because I wasn’t using with people … But I could not use less … There’s something we need to learn about, about how to tell if someone’s having an overdose … Make it like a CPR training, here’s how you check a pulse … this is the color someone’s lips should be… This stuff’s important. If you do not know how someone looks when they are overdosing, all the other shit’s out the window.’
In line with Savannah’s experience, over half of younger PWUF sought to learn actionable skills that minimized short-term risk.
Theme 2: While clinical providers advised treatment as a means of risk reduction, the treatment offered often did not align with PWUF priorities. Limited access to desired treatment types was a barrier from the provider perspective.
While 15 PWUF were in treatment at the time of the interview, all described cycles of relapse and recovery and reflected on how communication affected their engagement with treatment over time. For five providers (3 of 4 clinicians vs. 2 of 6 CHWs), their primary risk communication was encouraging PWUF to engage in treatment (including residential treatment, detoxification, and/or medications), yet PWUF often described not feeling ‘ready’ to consider treatment at the time of communication and/or experienced cumbersome logistics to treatment: ‘She offered me either one or the other, but I have to go through a series of appointments for the methadone … Right now – I don’t know if my readiness is there.’ (Kathy, 35+) Resource-strapped CHWs, while less frequently engaged in promoting treatment directly, discussed their struggle to link PWUF to their preferred treatment options. Antonio said, ‘I know the real problem is we don’t have enough treatment beds … We can do what we can do to keep them alive but there’s not enough’. Four of the providers described that younger PWUF had less social support, which sometimes impeded efforts to support treatment: ‘[People in their twenties], if they’re still using, they mostly feel like they have no help or no one to help them or they feel like everyone has pretty much given up on them … The older population sometimes that happens but it’s rare.’(Lydia). When younger people were connected with family or support networks, involving these supports in efforts to access treatment was critical.
Clinical providers described alternative communication strategies when treatment was not desired. One incorporated personalized goal setting into clinical interactions to retain PWUF in health care:
‘I talk about it up front…and [identify] what are that person’s goals. And some people might say ‘never inject again’. And that’s great. But other people might like to go back to work or not have to put all [their] time seeking out fentanyl; so like using once a week actually is their goal … And so I talk a lot about how it might take time … and our goals generally are in line with whatever their goal is.’ (Maya, Clinical Provider)
Utilizing a partnership rather than a compliance model, this provider identified goal-concordant risk reduction strategies that they felt PWUF were more likely to implement.
Theme 3: PWUF valued risk communication when providers prioritized developing rapport and being compassionate; an approach facilitated in community settings more readily than in clinical care.
PWUF and providers detailed discussing a range of harm reduction strategies including naloxone, starting low and going slow, using in groups, using in public if alone, and safe injection practices. For PWUF across the age spectrum compassionate, trust-building approaches were preferred and conveyed through cultivating personal connections, listening and asking questions, consistent messaging, and balancing honesty with words of encouragement. Messages like ‘[you] are not alone’ (Matteo, 18–25) paired with non-’sugar coated’ language, ‘Pretty much just like they tell you the truth. You’re going to die out there.’ (Leandro, 35+), helped PWUF feel supported and empowered, yet accountable.
CHWs, like Camila below, described a variety of light-touch strategies to initiate risk conversations with a focus on relationship building, which were appreciated by PWUF:
‘So [the tip of the day] is usually around two to three sentences. We make them on a quarter sheet of paper … So if somebody comes in, they do not want to talk, you can just sense by how they said hello or how they just look …we provide them with the syringes and whatever they may need. We’re like – okay, this is our tip of the week – and just staple it to a bag that we give them … And what normally happens is they read it and they ask a question.’
CHWs found displaying active curiosity to be rapport building, helped them learn about fentanyl, and message safe practices in ways that were concordant with PWUFs’ preferences:
‘I would use fentanyl and they’d be like, Feddy. And so, if they use that word in a conversation, I will use it back because I’m using their language .… If you say something I do not understand, I need to ask you what that means. And I think that’s what makes overdose prevention messaging for a specific population so important, is really listening to the people. So that our messaging matches their experience.’ (Denise, CHW)
PWUF valued people who stuck with them, even if relationships with clinicians felt fragile at times when using and reassurance from clinicians was not universal. CHWs suggested that perceived power dynamics between PWUF and clinicians may compromise harm reduction delivery, stemming in part from clinicians holding the power to prescribe medications:
‘When people are on things like Suboxone and Methadone that they do not want to have that discussion with their provider … Every person who sees the doctor is offered Narcan. They do not take Narcan from the doctor. They take it from me. Why is that? The doctor controls the prescription … They do not want to take it. They’ll take it from me when I do group … different power dynamic.’ (Denise, CHW)
Clinical providers, who faced structural barriers such as time-crunched and infrequent PWUF encounters, sometimes described prioritizing compliance-oriented testing over rapport building. One provider, Stephanie, addressed this tension by describing results via open-ended questions and ‘we’ language: ‘So, you said you hadn’t used. We found a surprising result - are you struggling? How can we support you?”
Another trusted source of information for 13 PWUF was people with lived experience, who were considered most credible:
‘If you are about to go skydiving, you do not want to talk about some guy who’s only seen it in movies. You want someone who’s actually jumped out of a plane and can describe to you what’s the best way not to die jumping out of said plane. You know what I mean? So personal experience is always best.’ (Brent, 18–25)
However, participants agreed that messages could be conveyed effectively by anyone displaying compassion. Though structural barriers to compassionate care persist, these obstacles were lessened by individual displays of empathy.
DISCUSSION
This exploratory study used qualitative interviews to characterize how people who use fentanyl and providers engaged in and responded to overdose risk communication. Younger people described fentanyl as posing an immediate risk of non-fatal overdose, but described feeling immune to fatal overdose, and seemed less likely to describe behavior modifications in response to overdose or risk communication. Most older PWUF appeared to perceive fentanyl as heightening risk of death and long-term health consequences, and many avoided fentanyl when possible. Treatment was often offered as the primary means of risk reduction in clinical settings, but options were not consistently aligned with PWUF desires. For PWUF of all ages, compassion was described as integral to successful risk communication.
Risk perceptions identified by younger participants in this study were consistent with research demonstrating that young adults display feelings of immunity to harm, which poses challenges to risk communication, as voiced by providers in the study [32,36,37]. There remains a need to examine factors related to both a sense of immunity and participation in risk-reduction behaviors, which may be attributable to experiential, developmental, biological, environmental and/or social circumstances. Despite some younger participants’ downplaying of their own fatality risk in using fentanyl, they did express a need for concrete information about overdose prevention/response and treatment linkages. For this group, there are a few approaches that may be effective. One approach may be adapting existing short, skills and knowledge-based trainings paired with naloxone distribution [20,46]. Elements of these trainings could be specifically tailored and tested to identify messaging that best targets and overcomes possible barriers to using harm reduction behaviors, including the belief of low risk of fatal overdose. Second, ensuring that substance use providers offer a continuum of overdose prevention services from harm reduction to medication treatment may engage young adults.
Communication strategies characterized as universally preferred and effective by both age groups included individual goal setting, a component of motivational interviewing (MI) methods. MI counseling is used to help individuals negotiate ambivalence and realize personal goals. It is well-studied, although data is mixed about its effectiveness among people who use substances [47-50]. PWUFs’ desires for active listening and honest, direct language reflected MI’s principles of empathy and discrepancy development (how current behavior differs from desired behavior). Provider elicitation of PWUF goals and use of encouraging words can promote self-efficacy [51]. Alignment between PWUF preferences and strategies they endorsed as effective suggest that MI elements may enhance the delivery of fentanyl-related risk communication. Two small randomized controlled trials have demonstrated MI’s effectiveness at reducing overdose risk behaviors in community and health care settings [52,53]. If further demonstrated to be effective, these models will provide pathways to integrating MI into overdose prevention settings.
PWUF also sought risk communicators who conveyed messages compassionately, which is consistent with the longstanding literature on patient-provider communication, where active listening and displays of compassion build trust and promote improved health outcomes [54]. In our sample, a majority of participants sought involvement of individuals with lived experience. Findings suggest that peer engagement may be a favorable conduit for risk communication. Supported by recent government funding, many states are currently implementing peer engagement strategies [55-60]. Though models vary, peers can address a range of needs, including information (e.g. overdose training), affiliation (e.g. social support), and instrumental support (e.g. resource linkage). Peers may also address providers’ perceived lack of social support for young people using fentanyl. While studies illustrate success in peer engagement, limited evidence demonstrates impacts on outcomes such as reduced substance use [61,62]. Future experimental studies should isolate the effects of peer engagement within PWUF communities on harm reduction and overdose outcomes.
From a systems perspective, PWUF in our study highlighted two areas that they perceived as underdeveloped in current treatment models. PWUF described that their preferred harm reduction approaches are more often accessed via community organizations, while treatment is more heavily focused within health care settings. Integrated care models that remove silos between primary care, outreach, harm reduction counseling, and treatment services among people using opioids are needed. Existing integrated care models include core program elements such as primary care coordination, delivering services in community-based settings, and providing substance use specialty support [63,64]. Studies of these models highlight the importance of wrap around services (e.g. transportation, telephone assistance) and in-person hand-offs in PWUF engagement and retention [64,65]. Touchpoints with multiple providers and flexible structures, such as variable clinic hours and group visit models, encourage both efficient care and increased PWUF engagement and could be leveraged more broadly to include community partners [66,67]. Second, some PWUF and CHWs suggested structural barriers in health care relationships may deter engagement and prohibit use of such integrated care models. Hawk et al. have published principles to guide the integration of harm reduction into health care settings [25]. At a minimum, improvements in coordination between organizations providing services along the continuum harm reduction to treatment are critical. The National Harm Reduction Coalition, based in New York, provides trainings for a variety of organizations that seek to scale harm reduction and integrate services across clinical and community settings [68], providing one path for promoting comprehensive services for people at all stages in their addiction.
The scope of this study is both a strength and limitation. By interviewing PWUF and providers, we elucidated the information and delivery preferences of stakeholders involved in traditional risk communication dyads. Examining age differences confirmed that neither PWUF nor provider groups were homogeneous and engaging with diverse perspectives is important for intervention development. This study’s focus on age limited an intersectional analysis of how other identities or circumstances, including gender, race, or housing status, influence risk communication. Further, our age comparisons may be vulnerable to survival bias and cohort effects, such that the older participants may have been risk-averse and thus survived longer, rather than older people become more risk-averse. Fully characterizing the impact of risk communication on behaviors over time requires robust longitudinal approaches. Focusing exclusively on the PWUF-provider relationship hindered interrogation of the full network of actors operating in the overdose risk reduction environment, including caregivers and policymakers. Also, many of our participants were engaged in treatment and/or harm reduction services at the time of interview, which may exclude the perspectives of those most immediately vulnerable to fentanyl overdose. These missing voices limit a holistic understanding of risk communication, and the impact of connection to treatment and support services on risk perceptions remains unknown. The purpose of this study was exploratory in nature, and subsequent work is needed to directly measure and compare potential age-based differences in perceptions and behaviors across time and in various settings. Future research should consider how PWUF can inform comprehensive risk communication at individual, community, and policy levels.
CONCLUSION
This study raises the possibility that PWUFs’ fentanyl-related risk communication experiences and preferences may vary by age. The role of age in risk communication preferences warrants further investigation. Longitudinal approaches that examine risk trajectories and behaviors over time and their role in characterizing the influence of age on engagement in risk communication and overdose prevention. Motivational interviewing techniques and using peers to engage PWUF likely offer promising approaches for enhancing multi-disciplinary risk communication across all ages. Future research should incorporate a diverse sample of PWUFs’ voices in intervention development and explore communication strategies and integrated care systems that address individual and structural barriers to behavior modification and impart practical skills to navigate them.
Acknowledgements
This project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI Grant Number 1UL1TR001430. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Dr Bagley’s work was supported in part by 1K23DA044324-01. The authors would like to thank staff and outreach workers at Access, Harm Reduction, Overdose Prevention and Education (AHOPE), The Engagement Center, and Project TRUST for assisting with recruitment to this study.
Footnotes
Declaration of interests
None.
References
- 1.Overdose Death Rates: National Institute on Drug Abuse; 2019. [updated March 2020]. Available at: https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates] (accessed 18 August 2019).
- 2.Data Brief. Opioid-Related Overdose Deaths Among Massachusetts Residents: Massachusetts Department of Public Health; 2020. Available at: https://www.mass.gov/doc/opioid-related-overdose-deaths-among-ma-residents-february-2020/downfoad (accessed 20 June 2020). [Google Scholar]
- 3.Scholl L, Seth P, Kariisa M, Wilson N, Drug B. G. Opioid-involved overdose deaths—United States, 2013–2017. Morb Mortal Wkly Rep 2019; 67: 1419–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gladden RM, O’Donnell J, Mattson C, Seth P Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine—25 states, July–December 2017 to January–June 2018. Morb MortalWkly Rep 2019; 68: 737–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Armenian P, Whitman J, Badea A, Johnson W, Drake C, Dhillon S, et al. Notes from the field: unintentional fentanyl overdoses among persons who thought they were snorting cocaine—Fresno, California, January 7. 2019. Morb Mortal Wkly Rep 2019; 68: 687–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Tomassoni A, Hawk K, Jubanyik K, Nogee D, Durant T, Lynch K, et al. Multiple fentanyl overdoses—New Haven, Connecticut, June 23, 2016. Morb Mortal Wkly Rep 2017; 66: 107–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Fischer B, Jones W, Tyndall M, Kurdyak P Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing—exploratory analyses from Canada. BMC Public Health 2020; 20: 143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ciccarone D The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy 2019; 71: 183–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mars S, Rosenblum D, Ciccarone D Illicit fentanyls in the opioid street market: desired or imposed? Addiction 2019; 114: 774–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ciccarone D, Ondocsin J, Mars SG Heroin uncertainties: exploring users’ perceptions of fentanyl-adulterated and - substituted heroin. Int J Drug Policy 2017; 46: 146–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Mars SG, Ondocsin J, Ciccarone D Sold as heroin: perceptions and use of an evolving drug in Baltimore, MD. J Psychoact Drugs 2018; 50: 167–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gill H, Kelly E, Henderson G How the complex pharmacology of the fentanyls contributes to their lethality. Addiction 2019; 114: 1524–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mars SG, Ondocsin J, Ciccarone D Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduct J 2018; 15: 26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J 2018; 15: 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the southeastern United States. Int J Drug Policy 2019; 63: 122–8. [DOI] [PubMed] [Google Scholar]
- 16.Gaeta J, Bock B, Takach M. Providing a Safe Space and Medical Monitoring to Prevent Overdose Deaths. Health Affairs Blog [internet]. 2016. Available at: https://www.healthaffairs.org/do/10.1377/hblog20160831.056280/full/ (accessed 14 April 2020). [Google Scholar]
- 17.Kral A, Davidson P Addressing the nation’s opioid epidemic: lessons from an unsanctioned supervised injection site in the US. Am J Prev Med 2017; 53: 919–22. [DOI] [PubMed] [Google Scholar]
- 18.Latkin CA, Dayton L, Davey-Rothwell MA, Tobin Fentanyl and drug overdose: perceptions of fentanyl risk, overdose risk behaviors, and opportunities for intervention among people who use opioids in Baltimore. USA. Subst Use Misuse 2019; 54: 998–1006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kerensky T, Walley AY Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know. Addict Sci Clin Pract 2017; 12: 4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Fairbairn N, Coffin P, Walley AY Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challengesv and innovations responding to a dynamic epidemic. Int J Drug Policy 2017; 46: 172–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Freeman R, French J What is the addicts’ grapevine when there’s ‘bad dope’? An investigation in New Jersey. Public Health Rep 1995; 110: 621–4. [PMC free article] [PubMed] [Google Scholar]
- 22.Soukup-Baljak Y, Greer A, Amlani A, Sampson O, Buxton J Drug quality assessment practices and communication of drug alerts among people who use drugs. Int J Drug Policy 2015; 26: 1251–7. [DOI] [PubMed] [Google Scholar]
- 23.Kerr T, Small W, Hyshka E, Maher L, Shannon K ‘It’s more about the heroin’: injection drug users’ response to an overdose warning campaign in a Canadian setting. Addiction 2013; 108: 1270–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Park JN, Weir BW, Allen ST, Chaulk P, Sherman SG Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore. MD. Harm Reduct J 2018; 15: 34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hawk M, Coulter RWS, Egan JE, Fisk S, Reuel Friedman M, Tula M, et al. Harm reduction principles for healthcare settings. Harm Reduct J 2017; 14: 70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.National Research Council (US) Committee on Risk Perception and Communication Improving Risk Communication. Washington, DC: National Academy Press; 1989. [Google Scholar]
- 27.International Harm Reduction Association. What is Harm Reduction? London: International Harm Reduction Association; 2020. Available at: https://www.hri.global/what-is-harm-reduction (accessed 2 July 2020).
- 28.Moore D Governing street-based injecting drug users: a critique of heroin overdose prevention in Australia. Soc Sci Med 2004; 59: 1547–57. [DOI] [PubMed] [Google Scholar]
- 29.Cho H,Reimer T,McComas K The Sage Handbook of Risk Communication. Thousand Oaks, CA: Sage Publications Ltd; 2015. [Google Scholar]
- 30.Speaking of Health Assessing Health Communication Strategies for Diverse Populations. Washington, DC: Institute of Medicine; 2002. [PubMed] [Google Scholar]
- 31.Marshall BDL, Yedinak JL, Goyer J, Green TC, Koziol JA, Alexander-Scott N Development of a statewide, publicly accessible drug overdose surveillance and information system. Am J Public Health 2017; 107: 1760–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Steinberg L A social neuroscience perspective on adolescent risk-taking. Develop Rev 2008; 28: 78–106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Cedarbaum ER, Banta-Green CJ Health behaviors of young adult heroin injectors in the Seattle area. Drug Alcohol Depend 2016; 158: 102–9. [DOI] [PubMed] [Google Scholar]
- 34.Neira-León M, Barrio G, Bravo MJ, Brugal MT, de la Fuente L, Domingo-Salvany A, et al. Infrequent opioid overdose risk reduction behaviours among young adult heroin users in cities with wide coverage of HIV prevention programmes. Int J Drug Policy 2011; 22: 16–25. [DOI] [PubMed] [Google Scholar]
- 35.Calvo M, MacFarlane J, Zaccaro H, Curtis M, Cabán M, Favaro J, et al. Young people who use drugs engaged in harm reduction programs in New York City: overdose and other risks. Drug Alcohol Depend 2017; 178: 106–14. [DOI] [PubMed] [Google Scholar]
- 36.Sussman S, Arnett JJ Emerging adulthood: developmental period facilitative of the addictions. Eval Health Prof 2014; 37: 147–55. [DOI] [PubMed] [Google Scholar]
- 37.Nower L, Derevensky JL, Gupta R The relationship of impulsivity, sensation seeking, coping, and substance use in youth gamblers. Psychol Addict Behav 2004; 18: 49–55. [DOI] [PubMed] [Google Scholar]
- 38.Morales KB, Park JN, Glick JL, Rouhani S, Green TC, Sherman SG Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities. Drug Alcohol Depend 2019; 204: 107547. [DOI] [PubMed] [Google Scholar]
- 39.Benoot C, Hannes K, Bilsen J The use of purposeful sampling in a qualitative evidence synthesis: a worked example on sexual adjustment to a cancer trajectory. BMC Med Res Methodol 2016; 16: 21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Mack K, Jones C, Ballesteros M Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas—United States. Morb Mort Wkly Rep Surveill Summ 2017; 66: 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Schreier M Qualitative Content Analysis in Practice. Thousand Oaks, CA: Sage; 2012. [Google Scholar]
- 42.Cho JY, Lee E-H Reducing confusion about grounded theory and qualitative content analysis: similarities and differences. Qual Rep 2014; 19: 1–20. [Google Scholar]
- 43.Ando H, Cousins R, Young C Achieving saturation in thematic analysis: development and refinement of a codebook. Compr Psychol 2014; 3: 1–7. [Google Scholar]
- 44.Eccleston P, Werneke U, Armon K, Stephenson T, MacFaul R Accounting for overlap? An application of Mezzich’s κ statistic to test interrater reliability of interview data on parental accident and emergency attendance. J Adv Nurs 2001; 33: 784–90. [DOI] [PubMed] [Google Scholar]
- 45.Burla L, Knierim B, Barth J, Liewald K, Duetz M, Abel T From text to codings: intercoder reliability assessment in qualitative content analysis. Nurs Res 2008; 57: 113–7. [DOI] [PubMed] [Google Scholar]
- 46.Piper TM, Rudenstine S, Stancliff S, Sherman S, Nandi V, Clear A, et al. Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City. Harm Reduct J 2007; 4: 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Osilla KC, Watkins KE, D’Amico EJ, McCullough CM, Ober AJ Effects of motivational interviewing fidelity on substance use treatment engagement in primary care. J Subst Abuse Treat 2018; 87: 64–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Chang Y-P, Compton P, Almeter P, Fox CH The effect of motivational interviewing on prescription opioid adherence among older adults with chronic pain. Perspect Psychiatr Care 2015; 51: 211–9. [DOI] [PubMed] [Google Scholar]
- 49.Bowman S, Eiserman J, Beletsky L, Stancliff S, Bruce RD Reducing the health consequences of opioid addiction in primary care. Am J Med 2013; 126: 565–71. [DOI] [PubMed] [Google Scholar]
- 50.Saunders B, Wilkinson C The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction 1995; 90: 415–24. [DOI] [PubMed] [Google Scholar]
- 51.Center for Substance Abuse Treatment (CSAT) Enhancing Motivation for Change in Substance Abuse Treatment, no. 25. Rockville, MD, CSAT; 1999. [PubMed] [Google Scholar]
- 52.Coffin PO, Santos G-M, Matheson T, Behar E, Rowe C, Rubin T, et al. Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: a pilot randomized controlled trial. PLOS ONE 2017; 12: e0183354–e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Bohnert ASB, Bonar EE, Cunningham R, Greenwald MK, Thomas L, Chermack S, et al. A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose. Drug Alcohol Depend 2016; 163: 40–7. [DOI] [PubMed] [Google Scholar]
- 54.Stewart MA Effective physician-patient communication and health outcomes: a review. Can Med Assoc J 1995; 152: 1423–33. [PMC free article] [PubMed] [Google Scholar]
- 55.Watson DP, Brucker K, McGuire A, Snow-Hill NL, Xu H, Cohen A, et al. Replication of an emergency department-based recovery coaching intervention and pilot testing of pragmatic trial protocols within the context of Indiana’s opioid state targeted response plan. J Subst Abuse Treat 2020; 108: 88–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Krawczyk N, Buresh M, Gordon MS, Blue TR, Fingerhood MI, Agus D Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: addressing a critical care gap. J Subst Abuse Treat 2019; 103: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.AnchorED. Recovery Supports for Overdose Survivors: The Providence Center; 2019. Available at: https://providencecenter.org/services/crisis-emergency-care/anchored (accessed 5 July 2020).
- 58.Powell KG, Treitler P, Peterson NA, Borys S, Hallcom D Promoting opioid overdose prevention and recovery: an exploratory study of an innovative intervention model to address opioid abuse. Int J Drug Policy 2019; 64: 21–9. [DOI] [PubMed] [Google Scholar]
- 59.Waye KM, Goyer J, Dettor D, Mahoney L, Samuels EA, Yedinak JL, et al. Implementing peer recovery services for overdose prevention in Rhode Island: an examination of two outreach-based approaches. Addict Behav 2019; 89: 85–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Samuels EA, Baird J, Yang ES, Mello MJ Adoption and utilization of an emergency department naloxone distribution and peer recovery coach consultation program. Acad Emerg Med 2019; 26: 160–73. [DOI] [PubMed] [Google Scholar]
- 61.Rief S, Braude L, Lyman DR, Dougherty RH, Daniels AS, Ghose SS, et al. Peer recovery support for individuals with substance use disorders: assessing the evidence. Psychiatr Serv 2014; 65: 853–61. [DOI] [PubMed] [Google Scholar]
- 62.Bassuk EL, Hanson J, Greene RN, Richard M, Laudet A Peer-delivered recovery support services for addictions in the United States: a systematic review. J Subst Abuse Treat 2016; 63: 1–9. [DOI] [PubMed] [Google Scholar]
- 63.Reif S, Brolin MF, Stewart MT, Fuchs TJ, Speaker E, Mazel SB The Washington State hub and spoke model to increase access to medication treatment for opioid use disorders. J Subst Abuse Treat 2019; 108: 33–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Fanucchi LC, Walsh SL, Thornton AC, Lofwall MR Integrated outpatient treatment of opioid use disorder and injection-related infections: a description of a new care model. Prev Med 2019; 128: 105760. [DOI] [PubMed] [Google Scholar]
- 65.Perrone J, Weiner SG, Nelson LS Stewarding recovery from the opioid crisis through health system initiatives. West J Emerg Med 2019; 20: 198–202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Weinstein ZM, Gryczynski G, Cheng DM, Quinn E, Hui D, Kim HW, et al. Tapering off and returning to buprenorphine maintenance in a primary care office based addiction treatment (OBAT) program. Drug Alcohol Depend 2018; 189: 166–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Edelman EJ, Oldfield BJ, Tetrault JM Office-based addiction treatment in primary care: approaches that work. Med Clin North Am 2018; 102: 635–52. [DOI] [PubMed] [Google Scholar]
- 68.National Harm Reduction Coalition. Training and Capacity Building: National Harm Reduction Coalition. 2020. Available at: https://harmreduction.org/our-work/training-capacity-building/

